Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

17th Closed Scientific Expert Meeting of the Editorial Board

Virtual meeting, 12th October 2022

PCSK9 and diabetes risk

PCSK9 and diabetes risk

Reports from the 17th Virtual Closed Scientific Expert Meeting of the Editorial Board  Wilfried Le Goff 

read more »
Keynote: Clinical utility of cIMT in determining management of children with heFH and of CTCA in determining treatment effects in children with hoFH

Keynote: Clinical utility of cIMT in determining management of children with heFH and of CTCA in determining treatment effects in children with hoFH

Reports from the 17th Virtual Closed Scientific Expert Meeting of the Editorial Board  Albert Wiegman 

read more »
How much reduction of Lp(a) is needed to translate into major clinical benefit? Setting the scene: Focus on PCSK9 inhibitors

How much reduction of Lp(a) is needed to translate into major clinical benefit? Setting the scene: Focus on PCSK9 inhibitors

Reports from the 17th Virtual Closed Scientific Expert Meeting of the Editorial Board  Pia Kamstrup 

read more »